Please assess the completion status of the following clinical trial:

Trial Title: Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Sydenham chorea moderate to severe (affecting activities of daily living) Raised ASOT titre~Exclusion Criteria:~* Mild Sydenham chorea (not affecting activities of daily living)~* Exclusion of systemic lupus erythematosus~* Exclusion of Wilson's disease~* Exclusion of toxin ingestion

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Group randomized to receive intravenous immunoglobulins in addition to standard therapy for sydenham's chorea
- 2 (Type: PLACEBO_COMPARATOR): Group randomized to receive standard intervention for sydenham's chorea alone

Based on this trial design, predict the completion outcome and termination type (if applicable).